Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors

Bone Marrow Transplantation

Volumn 20, Issue 6, 1997, Pages 465-471

  Carlo Stella, C ^a   Tabilio, A ^b   Regazzi, E ^a   Garau, D ^a   La Tagliata, R ^c   Trasarti, S ^c   Andrizzi, C ^c   Vignetti, M ^c   Meloni, G ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute myelogenous leukemia; Chemotherapy; Hematopoietic engraftment; Hematopoietic progenitors; LTC IC; Microenvironmental progenitors

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; METHYLCELLULOSE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BURST FORMING UNIT; CANCER CHEMOTHERAPY; CELL GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBROBLAST; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; STEM CELL; STROMA CELL;

EID: 0030815188     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700916     Document Type: Article

References (45)

1. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977; 91: 335-345.
2. Dexter TM. Regulation of hemopoietic cell growth and development: experimental and clinical studies. Leukemia 1989; 3: 469-474.
3. Gronthos S, Simmons PJ. The biology and application of human bone marrow stromal cell precursors. J Hematother 1996; 5: 15-23.
4. Owen ME, Cave J, Joyner CJ. Clonal analysis in vitro of osteogenic differentiation of CFU-F. J Cell Sci 1987; 87: 731-739.
5. Owen ME, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. CIBA Found Symp 1988; 136: 42-60.
6. Bennet JH, Joyner CJ, Triffitt JT, Owen ME. Adipocyte cells cultured from marrow have osteogenic potential. J Cell Sci 1991; 99: 131-139.
7. Greenberger JS. Toxic effects on the hematopoietic microenvironment. Exp Hematol 1991; 19: 1101-1109.
8. Betticher DC, Huxol H, Muller R et al. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Exp Hematol 1993; 21: 1517-1521.
9. Burnett AK. Autologous transplantation in acute leukemias, including purging. Curr Opin Oncol 1990; 2: 263-273.
10. Meloni G, De Fabritiis P, Petti MC, Mandelli F. BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood 1990; 75: 2282-2285.
11. Berman E, Heller G, Santorsa J et al. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood 1991; 77: 1666-1674.
12. Crump M, Keating A. Acute leukemia in adults. Curr Opin Hematol 1995; 2: 247-254.
13. Muus P, Zittoun R, Mandelli F et al. Randomized phase III study of induction (ICE vs MICE vs DCE) and intensive consolidation (IDIA vs NOVIA vs DIA) followed by stem cell transplantation in AML: EORTC/GIMEMA AML10 study. Eighth lnt Symp Autologous Marrow and Blood Transplant 1996; 4 (Abstr.).
14. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
15. Sutherland HJ, Eaves CJ, Eaves AC et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1990; 74: 1563-1570.
16. Castro-Malaspina H, Gay RE, Resnick G et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56: 289-301.
17. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
18. Carlo-Stella C, Mangoni L, Piovani G et al. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood 1994; 83: 1373-1380.
19. Carlo-Stella C, Regazzi E, Garau D et al. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukemic hematopoietic progenitor cell growth. Br J Haematol 1996; 93: 551-557.
20. Sutherland HJ, Eaves CJ, Lansdorp PM et al. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 1993; 78: 666-672.
21. Udomsakdi C, Lansdorp PM, Hogge DE et al. Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 1992; 80: 2513-2521.
22. Perkins S, Fleischman RA. Hematopoietic microenvironment: origin, lineage, and transplantability of the stromal cells in long-term bone marrow cultures from chimeric mice. J Clin Invest 1988; 81: 1072-1077.
23. Appelbaum FR. Marrow transplantation for hematologic malignancies: a brief review of current status and future prospects. Semin Hematol 1988; 25 (Suppl. 3): 16-22.
24. Gordon MY, Greaves MF. Physiological mechanisms of stem cell regulation in bone marrow transplantation and haemopoiesis. Bone Marrow Transplant 1989; 4: 335-338.
25. Chang J, Geary CG, Testa NG. Long-term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br J Haematol 1990; 75: 68-72.
26. Minderman H, Linssen P, van der Lely N et al. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state. Leukemia 1994; 8: 382-387.
27. Damon LE, Rug HS, Ries CA, Linker CA. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia. Bone Marrow Transplant 1996; 17: 93-99.
28. Ross EAM, Anderson N, Micklem HS. Serial depletion and regeneration of the murine hematopoietic system: implications for hematopoietic organization and the study of aging. J Exp Med 1982; 155: 432-444.
29. Li S, Champlin R, Fitchen JH, Gale RP. Abnormalities of myeloid progenitor cells after 'successful' bone marrow transplantation. J Clin Invest 1984; 75: 234-241.
30. Lemieux ME, Rebel VI, Lansdorp PM, Eaves CJ. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow 'switch' cultures. Blood 1995; 86: 1339-1347.
31. Petzer AL, Hogge DE, Lansdorp PM et al. Self-renewal of primitive human hematopoietic cells (long-term culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996; 93: 1470-1474.
32. Jones RJ, Wagner JE, Celano P et al. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 1990; 347: 188-189.
33. Fraser CC, Huffman R. Hematopoietic stem cell behavior: potential implications for gene therapy. J Lab Clin Med 1995; 125: 692-702.
34. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behaviour of hematopoietic stem cells. Cell 1986; 45: 917-927.
35. Jordan CT. Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 1990; 4: 220-232.
36. Abkowitz JL, Linenberger ML, Newton MA et al. Evidence for the maintenance of hematopoiesis in a large animal by sequential activation of stem cell clones. Proc Natl Acad Sci USA 1990; 87: 9062-9066.
37. Gordon MY, Blackett NM, Lewis JL, Goldman JM. Evidence for a mechanism that can provide both short-term and long-term haemopoietic repopulation by a seemingly uniform population of primitive human haemopoietic precursor cells. Leukemia 1995; 9: 1252-1256.
38. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guineapig bone marrow and spleen cells. Cell Tiss Kin 1970; 3: 393-403.
39. Ashton BA, Allen TD, Howlett CR et al. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop 1980; 151: 294-307.
40. Friedenstein AJ, Chailakhyan RK, Latsinik NV et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974; 17: 331-340.
41. Siena S, Castro-Malaspina H, Gulati SC et al. Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. Blood 1985; 65: 655-662.
42. Greenberger JS, Palaszynsky EW, Pierce JH. Biological effects of prolonged L-phenylalanine mustard treatment of murine long-term bone marrow cultures and IL-3-dependent haemopoietic progenitor cell lines. J Natl Cancer Inst 1985; 74: 247-253.
43. Gordon MY, Riley GP, Watt SM, Greaves MF. Compart-mentalization of a haemopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326: 403-405.
44. Kaufman CL, Colson YL, Wren SM et al. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436-2446.
45. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 1987; 328: 429-432.